Malaria

Counterfeiting, short supply hamper powerful Chinese herbal malaria drug

Tuesday, December 19, 2006 by: Jessica Fraser
Tags: healing herbs, Traditional Chinese Medicine, malaria

eTrust Pro Certified

Most Viewed Articles
Popular on Facebook
The five biggest lies about Ebola being pushed by government and mass media
White House admits staging fake vaccination operation to gather DNA from the public
Why does the CDC own a patent on Ebola 'invention?'
Ultraviolet light robot kills Ebola in two minutes; why doesn't every hospital have one of these?
EXCLUSIVE: Natural News tests flu vaccine for heavy metals, finds 25,000 times higher mercury level than EPA limit for water
Irrefutable proof we are all being sprayed with poison: 571 tons of toxic lead 'chemtrailed' into America's skies every year
Truvia sweetener a powerful pesticide; scientists shocked as fruit flies die in less than a week from eating GMO-derived erythritol
Russia taking McDonald's to court, threatens countrywide shutdown
Oregon man serving prison sentence for collecting rainwater on his own property
Senator who attacked Doctor Oz over dietary supplements received over $146,000 in campaign contributions from Big Pharma mega-retailer and Monsanto
Global warming data FAKED by government to fit climate change fictions
Healthy 12-year-old girl dies shortly after receiving HPV vaccine
HOAX confirmed: Michelle Obama 'GMOs for children' campaign a parody of modern agricultural politics
Ebola outbreak may already be uncontrollable; Monsanto invests in Ebola treatment drug company as pandemic spreads
Ben & Jerry's switches to non-GMO, Fair Trade ice cream ingredients
W.H.O. contradicts CDC, admits Ebola can spread via coughing, sneezing and by touching contaminated surfaces
Elliot Rodger, like nearly all young killers, was taking psychiatric drugs (Xanax)
BREAKING: CDC whistleblower confesses to MMR vaccine research fraud in historic public statement
Delicious
(NaturalNews) Doctors around the world have used a Chinese herbal drug -- artemisinin -- to effectively treat malaria since the 1960s, but recent supply shortages have sparked production of dangerous counterfeits, according to World Health Organization (WHO) officials.

Li Guiqiao, a professor at the Tropical Medicine Institute at Guangzhou University of Traditional Chinese Medicine, said he first used artemisinin on malaria patients when he was a village doctor in China's Yunnan province in 1974, at the government's request. Within hours, all 18 of his test patients felt better, and all recovered within a few days, Li said.

The leaves of the Artemisia annua -- sweet wormwood shrub -- have been used by Chinese herbalists as malaria medicine for more than 1,500 years, but in the late 1960s, scientists discovered its anti-malarial properties. Worldwide experts today believe artemisinin to be the most effective malaria drug.

However, after the WHO announced in 2001 that artemisinin should be used in combination with other drugs to slow drug resistance, the herbal shrub has been in short supply. Steep prices for the drug and a shortage of WHO-approved suppliers have led to the production of counterfeit artemisinin drugs, which have been implicated in a number of deaths.

"Fake drugs are all over the place and they are really creating problems in Asia," said Kevin Palmer, regional adviser for malaria in the Western Pacific at the WHO. "We are afraid they might get into Africa too as demand increases."

Though officials have begun spot-testing artemisinin drugs in the field, many counterfeits have reached the market.

"[Artemisinin drugs] are easy to fake," Palmer said. "Ninety-seven percent of fakes seized are just chalk. It's very worrying ... someone is making millions."

According to Wichai Satimai of the Public Health Ministry in Thailand -- where fake drugs are common -- counterfeit drugs aren't just a rip-off; they can also cause serious health consequences.

"Fake drugs cause complications and higher mortality," Wichai said. "If the drug is sub-standard -- say it has only 50 percent of the active ingredient -- it can't kill the whole protozoa (parasite). It will produce drug resistance."

With supplies already tight, the WHO has also only accredited two suppliers of official artemisinin-based combination therapies (ACTs) -- Swiss drug firm Novartis AG and Guilin Pharmaceuticals Company, based in China's southwestern city of Guilin.

Developing countries such as those in sub-Saharan Africa -- where 90 percent of the world's malaria deaths occur -- must purchase ACTs from those two suppliers in order to use money from the UN's Global Fund to Fight AIDS, Tuberculosis and Malaria. Critics have called for China and Vietnam to grow more artemisinin to help supply world demand, and for the WHO to accredit more manufacturers of ACTs.

###

Join over four million monthly readers. Your privacy is protected. Unsubscribe at any time.
comments powered by Disqus
Take Action: Support NaturalNews.com by linking back to this article from your website

Permalink to this article:

Embed article link: (copy HTML code below):

Reprinting this article:
Non-commercial use OK, cite NaturalNews.com with clickable link.

Follow Natural News on Facebook, Twitter, Google Plus, and Pinterest

Colloidal Silver

Advertise with NaturalNews...

Support NaturalNews Sponsors:

Advertise with NaturalNews...

GET SHOW DETAILS
+ a FREE GIFT

Sign up for the FREE Natural News Email Newsletter

Receive breaking news on GMOs, vaccines, fluoride, radiation protection, natural cures, food safety alerts and interviews with the world's top experts on natural health and more.

Join over 7 million monthly readers of NaturalNews.com, the internet's No. 1 natural health news site. (Source: Alexa.com)

Your email address *

Please enter the code you see above*

No Thanks

Already have it and love it!

Natural News supports and helps fund these organizations:

* Required. Once you click submit, we will send you an email asking you to confirm your free registration. Your privacy is assured and your information is kept confidential. You may unsubscribe at anytime.